We are live on ! Find out more
HP

Hikari Power Portfolio holdings

AUM $855M
1-Year Est. Return 14.24%
This Fund
S&P 500
This Quarter Est. Return
+4.68%
1 Year Est. Return
+14.24%
3 Year Est. Return
+53.45%
5 Year Est. Return
+75.51%
10 Year Est. Return
+220.8%
AUM
$774M
AUM Growth
+$32M
Cap. Flow
+$4.48M
Cap. Flow %
0.58%
Top 10 Hldgs %
60.49%
Holding
103
New
9
Increased
21
Reduced
5
Closed
13

Top Buys

Rank Stock Value
1
SGYP
Synergy Pharmaceuticals, Inc Common Stock
SGYP
+$3.41M
2
AMGN icon
Amgen
AMGN
+$2.71M
3
POT
Potash Corp Of Saskatchewan
POT
+$1.87M
4
DVA icon
DaVita
DVA
+$1.41M
5
ESRX
Express Scripts Holding Company
ESRX
+$1.36M

Top Sells

Rank Stock Value
1
SRCL
Stericycle Inc
SRCL
+$6.93M
2
DO
Diamond Offshore Drilling
DO
+$5.46M
3
BA icon
Boeing
BA
+$2.7M
4
CBI
Chicago Bridge & Iron Nv
CBI
+$1.98M
5
OPK icon
Opko Health
OPK
+$917K

Sector Composition

Rank Sector Weight
1 Financials 39.59%
2 Healthcare 25.46%
3 Technology 10.29%
4 Industrials 10.13%
5 Energy 5.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BIIB icon
26
Biogen
BIIB
$30.1B
$7.11M 0.92%
22,720
– –
XOM icon
27
ExxonMobil
XOM
$657B
$6.68M 0.86%
81,493
– –
ESRX
28
DELISTED
Express Scripts Holding Company
ESRX
$6.24M 0.81%
98,560
+21,900
+29% +$1.36M
USB icon
29
US Bancorp
USB
$100B
$6.05M 0.78%
112,900
– –
CSCO icon
30
Cisco
CSCO
$475B
$5.51M 0.71%
163,890
– –
BMY icon
31
Bristol-Myers Squibb
BMY
$130B
$5.41M 0.7%
84,800
+16,100
+23% +$940K
BDX icon
32
Becton Dickinson
BDX
$49.4B
$4.47M 0.58%
23,370
– –
SGYP
33
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
$4.35M 0.56%
1,500,000
+1,000,000
+200% +$3.41M
VOO icon
34
Vanguard S&P 500 ETF
VOO
$1.03T
$4.25M 0.55%
18,400
+4,900
+36% +$1.11M
MDT icon
35
Medtronic
MDT
$116B
$3.94M 0.51%
50,700
– –
GOOG icon
36
Alphabet (Google) Class C
GOOG
$4.19T
$3.74M 0.48%
78,000
– –
SRCL
37
DELISTED
Stericycle Inc
SRCL
$2.56M 0.33%
35,800
-94,200
-72% -$6.93M
DVAX
38
DELISTED
Dynavax Technologies
DVAX
$2.34M 0.3%
108,755
+25,000
+30% +$396K
KO icon
39
Coca-Cola
KO
$372B
$2.07M 0.27%
46,000
– –
TGTX icon
40
TG Therapeutics
TGTX
$7.64B
$1.9M 0.25%
160,000
+100,000
+167% +$1.14M
BDSI
41
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$1.77M 0.23%
601,285
– –
DO
42
DELISTED
Diamond Offshore Drilling
DO
$1.65M 0.21%
113,800
-453,900
-80% -$5.46M
AXP icon
43
American Express
AXP
$230B
$1.59M 0.21%
17,600
– –
MCD icon
44
McDonald's
MCD
$194B
$1.58M 0.2%
10,060
– –
CBI
45
DELISTED
Chicago Bridge & Iron Nv
CBI
$1.56M 0.2%
93,000
-129,000
-58% -$1.98M
ASHR icon
46
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
$1.58B
$1.51M 0.2%
51,900
+16,400
+46% +$468K
ACAD icon
47
Acadia Pharmaceuticals
ACAD
$5.07B
$1.51M 0.19%
40,000
-20,000
-33% -$651K
KHC icon
48
Kraft Heinz
KHC
$29.2B
$1.5M 0.19%
19,320
– –
PGNX
49
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$1.47M 0.19%
+200,000
New +$1.27M
MA icon
50
Mastercard
MA
$492B
$1.41M 0.18%
10,000
– –
1
2
3 4 5

Similar funds

QIM
Quest Investment Management Lake Oswego, Oregon $857M AUM 21.67% 1-Year Est. Return
NOCM
Night Owl Capital Management Greenwich, Connecticut $858M AUM 31.41% 1-Year Est. Return
OAM
Ophir Asset Management Sydney, Australia $859M AUM 59.08% 1-Year Est. Return
EPIMS
Evelyn Partners Investment Management Services London $850M AUM 20.89% 1-Year Est. Return
BCM
Benchstone Capital Management New York $860M AUM 32.46% 1-Year Est. Return
PCM
Parsifal Capital Management Greenwich, Connecticut $849M AUM 28.52% 1-Year Est. Return
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University Redwood City, California $849M AUM 55.45% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Hikari Power's Q3 2017 Portfolio in Review

As of Q3 2017, Hikari Power held 103 positions worth $774M, up 4.3% from $741M the previous quarter. Its ten largest holdings account for 60% of the portfolio.

Hikari Power's Q3 2017 filing shows 9 new, 21 increased, 5 reduced and 13 closed positions. Its largest new stake was Progenics Pharmaceuticals Inc: 200,000 shares worth $1.47M. The largest sale was Stericycle Inc, an estimated $6.93M.

By sector, the portfolio is most concentrated in Financials at 40% of assets, up from 39% a quarter earlier, followed by Healthcare and Technology.

  • Hikari Power's largest Q3 2017 buy was Progenics Pharmaceuticals Inc: 200,000 shares worth $1.47M.
  • Hikari Power added most to Synergy Pharmaceuticals, Inc Common Stock in Q3 2017, an estimated $3.41M increase.
  • Hikari Power's biggest Q3 2017 reduction was Stericycle Inc, cutting an estimated $6.93M.
  • Hikari Power fully exited Opko Health in Q3 2017, selling an estimated $917K.
  • Hikari Power's ten largest holdings make up 60% of its $774M portfolio in Q3 2017.
  • Hikari Power opened 9 new positions and closed 13 in Q3 2017.
  • Hikari Power's portfolio value rose 4.3% quarter-over-quarter to $774M.

Based on Hikari Power's 13F filing for Q3 2017, filed 8 Nov 2017.